Glycosylation improves α-chymotrypsin stability upon encapsulation in poly(lactic-co-glycolic)acid microspheres

Results in Pharma Sciences

Volumn 2, Issue 1, 2012, Pages 46-51

  Flores Fernández, Giselle M ^a   Griebenow, Kai ^a  

^a UNIVERSITY OF PUERTO RICO   (Puerto Rico)

Author keywords

Glycosylation; Microsphere; Nanoparticle; Protein aggregation; Sustained release

Indexed keywords

ACETIC ACID ETHYL ESTER; CHYMOTRYPSIN A; GLYCAN; LACTOSE; METHYL BETA CYCLODEXTRIN; MICROSPHERE; NANOPARTICLE; POLYGLACTIN;

ARTICLE; ENCAPSULATION; GLYCOSYLATION; METHODOLOGY; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN BINDING; PROTEIN SECONDARY STRUCTURE; PROTEIN SECRETION; PROTEIN STABILITY;

EID: 84867444873     PISSN: None     EISSN: 22112863     Source Type: Journal    
DOI: 10.1016/j.rinphs.2012.08.001     Document Type: Article

References (37)

1. Matsumoto A, Kitazawa T, Murata J, Horikiri Y, Yamahara H A novel preparation method for PLGA microspheres using non-halogenated solvents. Journal of Controlled Release 2008, 129:223-227.
2. Castellanos IJ, Al-Azzam W, Griebenow K Effect of the covalent modification with poly(ethylene glycol) on alpha-chymotrypsin stability upon encapsulation in poly(lactic-co-glycolic) microspheres. Journal of Pharmaceutical Sciences 2005, 94:327-340.
3. Gaspar MM, Blanco D, Cruz MEM, Alonso MJ Formulation of L-asparaginase-loaded poly(lactide-co-glycolide) nanoparticles: influence of polymer properties on enzyme loading, activity and in vitro release. Journal of Controlled Release 1998, 52:53-62.
4. Singh R, Lillard JW Nanoparticle-based targeted drug delivery. Experimental and Molecular Pathology 2009, 86:215-223.
5. Zhu G, Mallery SR, Schwendeman SP Stabilization of proteins encapsulated in injectable poly (lactide-co-glycolide). Nature Biotechnology 2000, 18:52-57.
6. Bertram JP, Jay SM, Hynes SR, Robinson R, Criscione JM, Lavik EB Functionalized poly(lactic-co-glycolic acid) enhances drug delivery and provides chemical moieties for surface engineering while preserving biocompatibility. Acta Biomaterialia 2009, 5:2860-2871.
7. Peréz C, Castellanos IJ, Costantino HR, Al-Azzam W, Griebenow K Recent trends in stabilizing protein structure upon encapsulation and release from bioerodible polymers. Journal of Pharmacy and Pharmacology 2002, 54:301-313.
8. Castellanos IJ, Cuadrado WO, Griebenow K Prevention of structural perturbations and aggregation upon encapsulation of bovine serum albumin into poly(lactide-co-glycolide) microspheres using the solid-in-oil-in water technique. Journal of Pharmacy and Pharmacology 2001, 53:1099-1107.
9. Castellanos IJ, Crespo R, Griebenow K Poly(ethylene glycol) as stabilizer and emulsifying agent: a novel stabilization approach preventing aggregation and inactivation of proteins upon encapsulation in bioerodible polyester microspheres. Journal of Controlled Release 2003, 88:135-145.
10. Kim HK, Park TG Microencapsulation of human growth hormone within biodegradable polyester microspheres: protein aggregation stability and incomplete release mechanism. Biotechnology and Bioengineering 1999, 65:659-667.
11. Rosenberg AS Effects of protein aggregates: an immunologic perspective. AAPS Journal 2006, 8:E501-E507.
12. Castellanos IJ, Flores G, Griebenow K Effect of cyclodextrins on alpha-chymotrypsin stability and loading in PLGA microspheres upon S/O/W encapsulation. Journal of Pharmaceutical Sciences 2006, 95:849-858.
13. Castellanos IJ, Cruz G, Crespo R, Griebenow K Encapsulation-induced aggregation and loss in activity of gamma-chymotrypsin and their prevention. Journal of Controlled Release 2002, 81:307-319.
14. Alexis F, Pridgen E, Molnar LK, Farokhzad OC Factors affecting the clearance and biodistribution of polymeric nanoparticles. Molecular Pharmaceutics 2008, 5:505-515.
15. Gelperina S, Kisich K, Iseman MD, Heifets L The potential advantages of nanoparticle drug delivery systems in chemotherapy of tuberculosis. American Journal of Respiratory and Critical Care Medicine 2005, 172:1487-1490.
16. Jahanshahi M, Babaei Z Protein nanoparticle: a unique system as drug delivery vehicles. African Journal of Biotechnology 2008, 7:4926-4934.
17. Flores-Fernandez GM, Pagán M, Almenas M, Solá RJ, Griebenow K Moisture-induced solid state instabilities in alpha-chymotrypsin and their reduction through chemical glycosylation. BMC Biotechnology 2010, 10:57.
18. Solá RJ, Al-Azzam W, Griebenow K Engineering of protein thermodynamic, kinetic, and colloidal stability: chemical glycosylation with monofunctionally activated glycan. Biotechnology and Bioengineering 2006, 94:1072-1079.
19. Solá RJ, Griebenow K Effects of glycosylation on the stability of protein pharmaceuticals. Journal of Pharmaceutical Sciences 2009, 98:1223-1245.
20. Solá RJ, Rodriguéz-Martinez JA, Griebenow K Modulation of protein biophysical properties by chemical glycosylation: biochemical insights and biomedical implications. Cellular and Molecular Life Sciences 2007, 64:2133-2152.
21. Pagán M, Solá RJ, Griebenow K On the role of protein structural dynamics in the catalytic activity and thermostability of serine protease subtilisin Carlsberg. Biotechnology and Bioengineering 2009, 103:77-84.
22. Solá RJ, Griebenow K Influence of modulated structural dynamics on the kinetics of alpha-chymotrypsin catalysis-insights through chemical glycosylation, molecular dynamics and domain motion analysis. FEBS Journal 2006, 273:5303-5319.
23. Habeeb AFSA Determination of free amino groups in proteins by trinitrobenzene sulfonic acid. Analytical Chemistry 1966, 14:328-336.
24. Montalvo BL, Pacheco Y, Sosa BA, Velez D, Sanchez G, Griebenow K Formation of spherical protein nanoparticles without impacting protein integrity. Nanotechnology 2008, 19:465103.
25. Castellanos IJ, Carrasquillo KG, Lopez JD, Alvarez M, Griebenow K Encapsulation of bovine serum albumin in poly(lactide-co-glycolide) microspheres by the solid-in-oil-in-water technique. Journal of Pharmacy and Pharmacology 2001, 53:167-178.
26. Carrasquillo KG, Costantino HR, Cordero RA, Hsu CC, Griebenow K On the structural preservation of recombinant human growth hormone in a dried film of a synthetic biodegradable polymer. Journal of Pharmaceutical Sciences 1999, 88:166-173.
27. Carrasquillo KG, Aponte Carro JC, Alejandro A, Diaz Toro D, Griebenow K Reduction of structural perturbations in BSA by non-aqueous microencapsulation. J Pharm. Pharmacol 2001, 53:115-120.
28. Carrasquillo KG, Sanchez C, Griebenow K Relationship between conformational stability and lyophilization-induced structural changes in chymotrypsin. Biotechnology and Applied Biochemistry 2000, 31:41-53.
29. Castellanos IJ, Griebenow K Improved alpha-chymotrypsin stability upon encapsulation in PLGA microspheres by solvent replacement. Pharmaceutical Research 2003, 20:1873-1880.
30. van Oss CJ, Good RJ, Chaudhury MK Solubility of proteins. Journal of Protein Chemistry 1986, 5:385-405.
31. Pai SS, Tilton RD, Przybycien TM Poly(ethylene glycol)-modified proteins: implications for poly(lactide-co-glycolide)-based microsphere delivery. AAPS Journal 2009, 11:88-98.
32. Griebenow K, Klibanov AM Lyophilization-induced reversible changes in the secondary structure of proteins. Proceedings of the National Academy of Sciences of the United States of America 1995, 92:10969-10976.
33. Flores-Fernandez GM, Sola RJ, Griebenow K The relation between moisture-induced aggregation and structural changes in lyophilized insulin. Journal of Pharmacy and Pharmacology 2009, 61:1555-1561.
34. Wu F, Jin T Polymer-based sustained-release dosage forms for protein drugs, challenges, and recent advances. AAPS PharmSciTech 2008, 9:1218-1229.
35. Yeo Y, Park KN Control of encapsulation efficiency and initial burst in polymeric microparticle systems. Archives of Pharmacal Research 2004, 27:1-12.
36. Leach WT, Simpson DT, Val TN, Anuta EC, Yu Z, Williams RO, Johnston KP Uniform encapsulation of stable protein nanoparticles produced by spray freezing for the reduction of burst release. Journal of Pharmaceutical Sciences 2005, 94:56-69.
37. Maa YF, Hsu CC Effect of primary emulsions on microsphere size and protein-loading in the double emulsion process. Journal of Microencapsulation 1997, 14:225-241.